---
figid: PMC6981486__ijms-21-00360-g009
figtitle: Antrodan alleviated the HFD-induced NAFLD via the
organisms:
- Mus musculus
- Rattus norvegicus
- Canis lupus familiaris
- Sus scrofa
- Homo sapiens
- Armoracia rusticana
- Notolabrus celidotus
- NA
pmcid: PMC6981486
filename: ijms-21-00360-g009.jpg
figlink: pmc/articles/PMC6981486/figure/ijms-21-00360-f009/
number: F9
caption: 'Antrodan alleviated the HFD-induced NAFLD via the. AMPK/SREBP-1c/PPARγ pathway
  HFD: High fat-high fructose diet. NAFLD: non-alcoholic fatty liver disease. ACC1:
  Acetyl-CoA carboxylase-1; AMPK: AMP-activated protein kinase; p-AMPK: phosphor-AMP-activated
  protein kinase; FAS: fatty acid synthase; FFA: free fatty acids; LCAc-CoA: long
  chain acyl CoA. PPARγ: Peroxisome proliferator-activated receptor gamma; SREBP-1c:
  Sterol regulatory element-binding protein-1c. TG: triglycerides; CPT-1: carnitine
  palmitoyltransferase I. The major part of fructose was transported into the hepatocytes
  is converted into glucose, which induces insulin resistance. The latter in turn
  increases the low energy index AMP/ATP, together with the adiponectin induced by
  Antrodan induces the conversion of AMPK into pAMPK. pAMPK increases the ratio NAD+/NADH
  and upregulates SIRT1. Working together with pAMPK, SIRT1 suppressed the insulin
  resistance and the level of TG, and the activity of FAS, ACC1 and malonyl-CoA biosynthesis,
  leading to enhanced CPT-1 and β-oxidation.'
papertitle: Antrodan Alleviates High-Fat and High-Fructose Diet-Induced Fatty Liver
  Disease in C57BL/6 Mice Model via AMPK/Sirt1/SREBP-1c/PPARγ Pathway.
reftext: Charng-Cherng Chyau, et al. Int J Mol Sci. 2020 Jan;21(1):360.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9531121
figid_alias: PMC6981486__F9
figtype: Figure
organisms_ner:
- Sus scrofa
redirect_from: /figures/PMC6981486__F9
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6981486__ijms-21-00360-g009.html
  '@type': Dataset
  description: 'Antrodan alleviated the HFD-induced NAFLD via the. AMPK/SREBP-1c/PPARγ
    pathway HFD: High fat-high fructose diet. NAFLD: non-alcoholic fatty liver disease.
    ACC1: Acetyl-CoA carboxylase-1; AMPK: AMP-activated protein kinase; p-AMPK: phosphor-AMP-activated
    protein kinase; FAS: fatty acid synthase; FFA: free fatty acids; LCAc-CoA: long
    chain acyl CoA. PPARγ: Peroxisome proliferator-activated receptor gamma; SREBP-1c:
    Sterol regulatory element-binding protein-1c. TG: triglycerides; CPT-1: carnitine
    palmitoyltransferase I. The major part of fructose was transported into the hepatocytes
    is converted into glucose, which induces insulin resistance. The latter in turn
    increases the low energy index AMP/ATP, together with the adiponectin induced
    by Antrodan induces the conversion of AMPK into pAMPK. pAMPK increases the ratio
    NAD+/NADH and upregulates SIRT1. Working together with pAMPK, SIRT1 suppressed
    the insulin resistance and the level of TG, and the activity of FAS, ACC1 and
    malonyl-CoA biosynthesis, leading to enhanced CPT-1 and β-oxidation.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - ACID
  - PRKAA1
  - SIRT1
  - PPARGC1A
  - CPT1A
  - CPT1B
  - Fructose
  - Fructose Fatty
  - Fructose-1-P
  - NADH
  - IMalonylCoA
---
